Browse All

Current Filters

CLEAR FILTER x

TITLE

Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy, Pharmacodynamics, and Immunogenicity in AChR+ Cohort (Week 52)

Author:Clarkson, Kristen   Utsugisawa, Kimiaki   Benatar, Michael   Ciafaloni, Emma   Leite, Maria   Vissing, John   Tang, Fengming   Peer, Cody J.   Cheng, Sue   Howard, James   Nowak, Richard   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Child Neurology and Developmental Neurology  

Program Number:S14.009  

Author Institution:Hanamaki General Hospital, Hanamaki, Japan  University of Miami, Miami, FL  University of Rochester Medical Center, Rochester, NY  Nuffield Department of Clinical Neurosciences - University of Oxford, Oxford, United Kingdom  University of Copenhagen, Copenhag  

Preclinical Characterization of MGAC-007, a First-in-Class Antigen Drug Conjugate for AChR? Myasthenia Gravis

Author:Oved, Kfir   Denkberg, Galit   Reef, Sharon   Arman, Inbar   Pinzur, Lena   Mazor, Roei D.   Harel, Ofer   Erez, Shir   Atiya, Yael   Dowery, Reem   Benatar, Michael   De Baets, Marc   Wolfe, Gil   Kaminski, Henry   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S14.010  

Author Institution:

A Real-world Cohort of Patients With Myasthenia Gravis: The PPD™ CorEvitas™ Myasthenia Gravis Registry

Author:Benatar, Michael   Middaugh, Nicole   Margolin, Zachary   Tremlett, Emily   Wertz, Debra   Wahl, Peter   Howard, James   

Session Name:P4: Neuromuscular and Clinical Neurophysiology (EMG): Neuromuscular Junction Disorders  

Topic:Multiple Sclerosis  

Program Number:P4.009  

Author Institution: